Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $489,711 | $230,440 | $4,158 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $12,822 | $633 | $826 |
| Total Curr. Assets | $502,533 | $231,073 | $4,984 |
| Property Plant & Equip (Net) | $845 | $815 | $636 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $59,199 | $0 | $0 |
| Other NC Assets | $6,618 | $2,094 | $1,083 |
| Total NC Assets | $66,662 | $2,909 | $1,719 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $569,195 | $233,982 | $6,703 |
| Liabilities | – | – | – |
| Payables | $4,508 | $3,186 | $5,137 |
| Short-Term Debt | $607 | $285 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $12,875 | $11,614 | $18,759 |
| Total Curr. Liab. | $17,990 | $15,085 | $23,896 |
| LT Debt | $131 | $372 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $59,199 | $0 | $0 |
| Other NC Liab. | $0 | $17 | $85 |
| Total NC Liab. | $59,330 | $389 | $85 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $131 | $657 | $0 |
| Total Liabilities | $77,320 | $15,474 | $23,981 |
| Equity | – | – | – |
| Pref Stock | $0 | $367,277 | $81,525 |
| Common Stock | $7 | $2 | $2 |
| Retained Earnings | -$221,016 | -$153,021 | -$101,036 |
| AOCI | $0 | -$0 | $0 |
| Other Equity | $712,884 | $4,250 | $2,231 |
| Total Equity | $491,875 | $218,508 | -$17,278 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $569,195 | $233,982 | $6,703 |
| Net Debt | -$488,973 | -$229,783 | -$4,158 |